Scientists test drug mix in healthy volunteers
NCT ID NCT07439250
Summary
This early-stage study aims to see if a common antifungal medication (fluconazole) changes how much of an experimental cancer drug (olomorasib) gets into a person's blood and how long it stays there. It involves 15 healthy participants who will stay overnight at a research center for about 7 weeks. The goal is to gather basic safety and interaction data to help design future cancer treatment studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fortrea Clinical Research Unit - Daytona Beach
RECRUITINGDaytona Beach, Florida, 32117-5116, United States
Conditions
Explore the condition pages connected to this study.